Menu
Back to Journals » OncoTargets and Therapy » Volume 6
B7-H3 is a new cancer-specific endothelial marker in clear cell renal cell carcinoma
Authors Qin X, Zhang H, Ye D, Dai B, Zhu Y, Shi G
Received 26 August 2013
Accepted for publication 4 October 2013
Published 15 November 2013 Volume 2013:6 Pages 1667—1673
DOI https://doi.org/10.2147/OTT.S53565
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 5
Xiaojian Qin,1,2 Hailiang Zhang,1,2 Dingwei Ye,1,2 Bo Dai,1,2 Yao Zhu,1,2 Guohai Shi1,2
1Department of Urology, Fudan University Shanghai Cancer Center, Shanghai, People's Republic of China; 2Department of Oncology, Fudan University Shanghai Medical College, Shanghai, People's Republic of China
Background: The purpose of this study was to validate B7-H3 as a new cancer-specific endothelial marker in clear cell renal cell carcinoma.
Methods: B7-H3 expression patterns were compared between cancer and paired adjacent normal renal parenchyma by immunohistochemistry in paraffin-embedded specimens from 200 consecutive patients with clear cell renal cell carcinoma from January to December 2010. Four corpus luteum specimens were used as physiologic angiogenesis controls. B7-H3 messenger (m)RNA levels representing circulating endothelial cells were analyzed in 24 peripheral blood samples using real-time polymerase chain reaction. Collection and processing of tissue and peripheral blood samples was performed in compliance with the Declaration of Helsinki.
Results: Cancer cell-specific expression of B7-H3 was detected in 19% of clear cell renal cell carcinoma specimens, and tumor vasculature B7-H3 expression was confirmed in 98% (196) of cases. A diffuse pattern of vascular B7-H3 expression was associated with multiple adverse clinical and pathologic features (P<0.001). B7-H3 expression was not detected in paired adjacent normal renal parenchyma or vessels, or in luteal blood vessels. The B7-H3 mRNA level of circulating endothelial cells in peripheral blood was significantly higher in metastatic clear cell renal cell carcinoma (P<0.001).
Conclusion: This pilot study indicates that B7-H3 is a cancer-specific endothelial marker of potential importance for the development of tumor-specific, vascular-targeted therapies, and is a prognostic marker in clear cell renal cell carcinoma.
Keywords: B7-H3, biomarkers, clear cell renal cell carcinoma, endothelial cell, kidney
© 2013 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.